Itron, Inc. (NASDAQ:ITRI) Receives Average Rating of “Moderate Buy” from Analysts

Itron, Inc. (NASDAQ:ITRIGet Free Report) has earned an average recommendation of “Moderate Buy” from the thirteen ratings firms that are covering the company, MarketBeat Ratings reports. Five analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $104.64.

ITRI has been the topic of a number of analyst reports. Canaccord Genuity Group lifted their price target on Itron from $115.00 to $120.00 and gave the company a “buy” rating in a research note on Thursday, June 20th. Robert W. Baird boosted their target price on Itron from $108.00 to $115.00 and gave the stock an “outperform” rating in a research report on Wednesday, March 13th. Oppenheimer boosted their target price on Itron from $100.00 to $110.00 and gave the stock an “outperform” rating in a research report on Friday, May 3rd. TD Cowen boosted their target price on Itron from $110.00 to $115.00 and gave the stock a “buy” rating in a research report on Friday, May 3rd. Finally, StockNews.com downgraded Itron from a “strong-buy” rating to a “buy” rating in a research report on Friday, June 28th.

Check Out Our Latest Stock Report on ITRI

Insider Transactions at Itron

In other news, CFO Joan S. Hooper sold 501 shares of the business’s stock in a transaction on Friday, May 24th. The stock was sold at an average price of $108.87, for a total value of $54,543.87. Following the completion of the transaction, the chief financial officer now directly owns 72,847 shares of the company’s stock, valued at $7,930,852.89. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In related news, CFO Joan S. Hooper sold 501 shares of the company’s stock in a transaction on Friday, May 24th. The stock was sold at an average price of $108.87, for a total value of $54,543.87. Following the completion of the transaction, the chief financial officer now directly owns 72,847 shares in the company, valued at $7,930,852.89. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Thomas Deitrich sold 873 shares of the company’s stock in a transaction on Friday, May 24th. The shares were sold at an average price of $108.87, for a total value of $95,043.51. Following the completion of the transaction, the chief executive officer now owns 206,163 shares of the company’s stock, valued at $22,444,965.81. The disclosure for this sale can be found here. Insiders sold a total of 1,775 shares of company stock valued at $192,613 over the last three months. 1.45% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Itron

Institutional investors have recently added to or reduced their stakes in the business. Trexquant Investment LP increased its stake in Itron by 18.4% during the fourth quarter. Trexquant Investment LP now owns 67,973 shares of the scientific and technical instruments company’s stock worth $5,133,000 after acquiring an additional 10,542 shares during the last quarter. Los Angeles Capital Management LLC acquired a new stake in Itron during the first quarter worth about $2,002,000. Vanguard Group Inc. increased its stake in Itron by 2.6% during the third quarter. Vanguard Group Inc. now owns 5,668,071 shares of the scientific and technical instruments company’s stock worth $343,372,000 after acquiring an additional 142,564 shares during the last quarter. Oppenheimer & Co. Inc. increased its stake in Itron by 91.1% during the fourth quarter. Oppenheimer & Co. Inc. now owns 30,568 shares of the scientific and technical instruments company’s stock worth $2,308,000 after acquiring an additional 14,573 shares during the last quarter. Finally, S&CO Inc. purchased a new stake in shares of Itron in the fourth quarter worth about $249,000. 96.19% of the stock is currently owned by institutional investors and hedge funds.

Itron Stock Up 0.7 %

Itron stock opened at $99.47 on Thursday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.90 and a quick ratio of 1.40. Itron has a 1-year low of $56.11 and a 1-year high of $111.00. The company has a market cap of $4.56 billion, a PE ratio of 28.58, a price-to-earnings-growth ratio of 0.95 and a beta of 1.45. The stock’s 50 day moving average price is $104.14 and its 200 day moving average price is $89.72.

Itron (NASDAQ:ITRIGet Free Report) last posted its quarterly earnings results on Thursday, May 2nd. The scientific and technical instruments company reported $1.24 earnings per share for the quarter, beating analysts’ consensus estimates of $0.85 by $0.39. Itron had a return on equity of 14.51% and a net margin of 7.03%. The firm had revenue of $603.44 million for the quarter, compared to the consensus estimate of $579.49 million. During the same period in the previous year, the business earned $0.49 earnings per share. The company’s revenue for the quarter was up 22.0% compared to the same quarter last year. On average, sell-side analysts predict that Itron will post 4 EPS for the current fiscal year.

Itron Company Profile

(Get Free Report

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.

Recommended Stories

Analyst Recommendations for Itron (NASDAQ:ITRI)

Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.